Locoregional CAR T Cells for the Treatment of CNS Tumors in Children: Investigational Drug Service Pharmacy Activities.
Nicholas A. Vitanza(Seattle Children's Hospital), Michael C. Jensen(Seattle Children's Hospital), Juliane Gust(University of Washington), Catherine Lindgren(Unknown), Susan Jacob, Julie R. Park(Seattle Children's Hospital), Joshua A. Gustafson(Seattle Children's Hospital), Michelle Choe(Baylor College of Medicine), Ashley Wilson(Center for Infectious Disease Research), Jessica Foster(Children's Hospital of Philadelphia), Erin Crotty(Seattle Children's Hospital), Rebecca Ronsley(Seattle Children's Hospital), Sarah Leary(Seattle Children's Hospital), Ada Kong(Seattle Children's Hospital), Alyssa Noll, Rebecca Gardner(Seattle Children's Hospital), Stephanie Mgebroff(Bloodworks Northwest), Navin Pinto(Seattle Children's Hospital), Adam Beebe, Elena Mano, Lisa R. Rogers(University of Michigan), Kimberly Abuan, Christopher T. Brown(Milagen (United States))
PubMed
August 1, 2024
Cited by 4
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k